How the DGT's position has evolved
Current position
Products from Chapter 30 of the Combined Nomenclature are taxed at 10% if they are not medicines, are not exempt, and are suitable for direct use by the final consumer. This latter requirement demands that the product can be applied directly to the patient due to its objective characteristics. If the product is a food supplement pursuant to Royal Decree 1487/2009, it is also taxed at 10%. In any other case, the general rate of 21% applies.
The DGT's position remains constant regarding the application of the reduced rate to Chapter 30 provided that concurrent requirements are met. The requirement that the product be for direct use by the final consumer has been maintained to avoid the general rate. The latest ruling introduces the condition of being a food supplement to determine the applicable rate.
Turning points
-
Establishes that products are taxed at 10% as long as they are considered food supplements pursuant to Royal Decree 1487/2009.
Analysis based on 89 of 90 rulings with a stated position. Updated 23 September 2026.